The therapeutic use of 177 Lu-PSMA-617 radioligand therapy in prostate cancer treatment: a review of literature and ongoing trials
Abstract Radioligand therapy is a targeted cancer treatment modality in which radioisotopes are utilized in the delivery of radiation at targeted cancer cells, with the goal of sparing normal cells. Prostate cancer is a well-known radiosensitive disease, historically treated with radioisotopes such...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer
2024-12-01
|
| Col·lecció: | Discover Oncology |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/s12672-024-01680-z |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|